Department B, Bechir Hamza Children's Hospital of Tunis, Faculty of Medicine of Tunis, University El Manar, Tunis, Tunisia.
AP-HP, Département de Biochimie-Biologie Moléculaire, Pharmacologie, Génétique Médicale, Hôpital Henri Mondor, Créteil, France.
Pediatr Allergy Immunol Pulmonol. 2022 Sep;35(3):124-128. doi: 10.1089/ped.2022.0023.
Mutations in the ATP-binding cassette transporter A3 () gene are one of the most common surfactant disorders leading to interstitial lung diseases (ILD). The clinical spectrum and severity of lung disease caused by ABCA3 deficiency due to missense variants is variable. A novel c.3135G>C (p.Gln1045His) mutation was identified at the homozygous state in 3 subjects from 2 unrelated families: one 19-month-old boy with severe ILD and his homozygous pauci-symptomatic mother, and one 10-year-old girl with moderate late-onset ILD. Corticosteroid pulses associated with hydroxychloroquine were beneficial for both children. We illustrate here the huge intra- and interfamilial phenotypic variability associated with the same homozygous missense mutation, and the benefit of identifying the disease for treatment, follow-up, and appropriate genetic counseling.
ATP 结合盒转运蛋白 A3 () 基因突变是导致间质性肺疾病 (ILD) 的最常见的肺表面活性物质代谢障碍之一。由于错义变异导致 ABCA3 缺乏引起的肺部疾病的临床谱和严重程度是可变的。在 2 个无血缘关系的家庭的 3 名受试者中均发现纯合状态的新型 c.3135G>C (p.Gln1045His) 突变:1 名 19 个月大的患有严重 ILD 的男孩及其纯合无症状母亲,和 1 名 10 岁患有中度迟发性 ILD 的女孩。皮质类固醇脉冲联合羟氯喹对两个孩子都有效。我们在此举例说明了与相同纯合错义突变相关的巨大的个体内和个体间表型变异性,以及识别疾病进行治疗、随访和适当遗传咨询的益处。